(Q41589751)

English

Intravenous immunoglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis--the Israeli experience. MS Study Group

scientific article published on April 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

1 reference

Europe PubMed Central

Intravenous immunoglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis--the Israeli experience. MS Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

0 references

author name string

A Achiron

1

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

Z Rotstein

2

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

Y Barak

3

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

I Sarova-Pinhas

4

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

publication date

1 April 1997

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

142-144

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

CD4+ murine T cell clones that express high levels of immunoglobulin binding belong to the interleukin 4-producing T helper cell type 2 subset

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300215

21 January 2018

Passage of intravenous immunoglobulin and interaction with the CNS.

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300215

21 January 2018

Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300215

21 January 2018

Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300215

21 January 2018

Intravenous gammaglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis: delineation of usage and mode of action

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300215

21 January 2018

Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300215

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300215

21 January 2018

Identifiers

10.1177/135245859700300215

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41589751&oldid=1924795003"